J. Kevin Buchi

Overview

J. Kevin Buchi received $2M in total compensation, including $139K in salary, at BioSpecifics Technologies in 2019.

Source: SEC filing on April 29, 2020.

Related executives

We found three more executives who work or worked at BioSpecifics Technologies.

Patrick Caldwell

BioSpecifics Technologies

Former Interim Principal Financial Officer

Thomas Wegman

BioSpecifics Technologies

Former President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer

Ronald Law

BioSpecifics Technologies

Former Interim Principal Executive Officer

News

You may also like